Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation ; volume:19 ; number:1 ; day:3 ; month:12 ; year:2022 ; pages:1-11 ; date:12.2022
Harm reduction journal ; 19, Heft 1 (3.12.2022), 1-11, 12.2022
- Creator
-
Corneli, Amy
Perry, Brian
Des Marais, Andrea
Choi, Yujung
Chen, Hillary
Lilly, Rebecca
Ayers, Denae
Bennett, Jesse
Kestner, Lauren
Meade, Christina S.
Sachdeva, Nidhi
McKellar, Mehri S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-022-00718-1
- URN
-
urn:nbn:de:101:1-2023021421124321252523
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
17.09.2025, 3:03 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Corneli, Amy
- Perry, Brian
- Des Marais, Andrea
- Choi, Yujung
- Chen, Hillary
- Lilly, Rebecca
- Ayers, Denae
- Bennett, Jesse
- Kestner, Lauren
- Meade, Christina S.
- Sachdeva, Nidhi
- McKellar, Mehri S.
- SpringerLink (Online service)
Other Objects (12)
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Correction to: Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Correction to: Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach